Filing Details
- Accession Number:
- 0000950170-25-088895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-23 14:39:22
- Reporting Period:
- 2025-06-20
- Filing Date:
- 2025-06-23
- Accepted Time:
- 2025-06-23 14:39:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1307632 | J Richard Hawkins | One Summit Square, 1717 Langhorne Newtown Road, Suite 300 Langhorne PA 19047 | No | No | No | No |
Transaction Summary
Purchased: | 48,225 shares | Avg. Price: $2.04 | Total Value: $98,571.90 |
Number of Shares After Transactions: | 115,466 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-20 | 48,225 | $2.04 | 115,466 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price is a weighted average purchase price. The purchase prices ranged from $2.0345 to $2.045. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.